Results 191 to 200 of about 20,950 (257)

Analysis of the Efficacy and Safety of Secukinumab Combined with Surgical Treatment for Hidradenitis Suppurativa: A Real-World Retrospective Study in China. [PDF]

J Inflamm Res
Liu X, Yuan C, Kang Y, Zhang J, Li Y, Wang R, Ding C, Zhang J, Xing W.   +8 more
europepmc   +1 more source

Comprehensive assessment of 5 interleukin inhibitors for the treatment of psoriasis: scientific guidance based on drug selection recommendations for Chinese medical institutions. [PDF]

J Pharm Policy Pract
Zhang JX, Li WW, Qiu ZK, Lai S.
europepmc   +1 more source

Managing leprosy reactions with secukinumab: Insights from a case series. [PDF]

Rev Soc Bras Med Trop
Gomide LV, Brufatto JPT, Kucarz TJ, Velho PENF, França AFEDC.   +4 more
europepmc   +1 more source

Alterations of the Gut Microbiome in Psoriasis before and after Treated with Secukinumab.

Indian J Dermatol
Fang L, Cheng S, Zuo C, Zhang L.
europepmc   +1 more source

Secukinumab Plus Upadacitinib for the Treatment of Severe Hidradenitis Suppurativa and Associated Immune-Mediated Comorbidities: A Case Series. [PDF]

Dermatol Ther (Heidelb)
Melgosa Ramos FJ, Martínez Ruiz E, Galarreta Pascual M, Sanz-Motilva V, Martorell A.   +4 more
europepmc   +1 more source

Secukinumab Efficacy Predictors in Korean Hidradenitis Suppurativa: A 48-Week Clinical Trial Analysis. [PDF]

Dermatol Pract Concept
Nguyen NH, Lee SG, Ham S, Lee JH, Lee YI.   +4 more
europepmc   +1 more source

Predictors of Successful Secukinumab Dose Tapering in Moderate-to-Severe Psoriasis: A Retrospective Study. [PDF]

Psoriasis (Auckl)
Chen J, Xiao Z, Zeng X, Xiang N, Luo R, Chen R, Lin B, Ke H, Gong T, Ji C.   +9 more
europepmc   +1 more source

IL-17A complexes with therapeutic antibodies exhibit distinct size distributions, potentially contributing to clinically observed immunogenicity. [PDF]

MAbs
Ungan D, Be C, Baczyk P, Mittermeier S, Lehmann S, Wiesmann C, Huber T, Kolbinger F, Rondeau JM.   +8 more
europepmc   +1 more source

Secukinumab-Induced Interstitial Pneumonia in a Patient with Psoriasis. [PDF]

Balkan Med J
Li S, Dai R, Xu Q.
europepmc   +1 more source

Strategies for Optimal Use of Biological Therapies in Managing Psoriasis: Focus on Secukinumab. [PDF]

Dermatol Ther (Heidelb)
Balato A, Burlando M, Campanati A, Costanzo A, Chiricozzi A, Gisondi P, Malagoli P, Micali G, Psoriasis Working Group.   +8 more
europepmc   +1 more source